search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Nerve Growth Factor β validation study


- candidate number28513
- NTR NumberNTR6990
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR30-jan-2018
- Secondary IDsNL63048.029.17 CCMO (Toetsingonline)
- Public TitleNerve Growth Factor β validation study
- Scientific TitleNerve Growth Factor β measurement method validation study: dried blood spot analysis and saliva sample testing compared to venous serumí»
- ACRONYM
- hypothesisDried blood spot analysis is a reliable method to measure Nerve Growth Factor β.
- Healt Condition(s) or Problem(s) studiedHealthy volunteers, Nerve growth factor β
- Inclusion criteria- Both male and female volunteers.
- 18 years or older.
- Willingness to give informed consent, to donate venous blood, dried blood spots obtained through a finger puncture, saliva and complete a questionnaire.
- Sufficient command of Dutch or English language and capable of understanding participants information.
- Exclusion criteria- Contraindications for donating blood (phlebitis, dermatitis, psoriasis, lymphedema, arterial venous fistula, hematoma on or around insert place, mamma-amputation or axillary dissection of lymph nodes).
- Age younger than 18 years.
- Poor dental condition.
- Volunteers who brushed their teeth within 45 minutes prior to sample collection.
- Volunteers who had dental work within 24 hours prior to sample collection.
- Volunteers who had their last meal, sigarette, or drank anything except for water within 60 minutes prior to sample collection.
- mec approval receivedyes
- multicenter trialno
- randomisedno
- group[default]
- TypeSingle arm
- Studytypeobservational
- planned startdate 7-feb-2018
- planned closingdate1-nov-2018
- Target number of participants60
- InterventionsQuestionaire, saliva sampling, serum sampling, dried blood spot collection.
- Primary outcomeThe main study parameters will be the correlation between the DBS and saliva methods compared to venous blood sampling. In order to do so, NGF-β concentrations (pg/ml) for each method will be measured. The difference between saliva testing and venous blood and the difference between dried blood spot and venous blood will be calculated.
- Secondary outcomeIn the informed consent volunteers are asked for their permission to use stored samples to measure other reproduction related hormones.
- TimepointsQuestionaire will be completed at home, before the first visit. During the first visit, all samples will be collected. Afterwards all samples will be analyzed.
- Trial web site
- statusplanned
- CONTACT FOR PUBLIC QUERIES Nienke Schouten
- CONTACT for SCIENTIFIC QUERIES Nienke Schouten
- Sponsor/Initiator VU University Medical Center
- Funding
(Source(s) of Monetary or Material Support)
VU University Medical Center
- Publications
- Brief summaryRationale: There are roughly two types of ovulation: spontaneous and induced. Copulation is the speculated mechanism behind induced ovulation. The ovulation induction substance in semen has been identified as nerve growth factor β (NGF-β). In animal studies, semen plasma derived NGF-β indeed has an effect on female ovulation, follicle development and a luteotropic effect. The role of NGF-β on human ovulation has never been studied. It is known that NGF-β plays an important role in many different types of human tissue, for instance the nervous system and immune system. All studies use venous blood to measure the NGF-β concentration. However, in order to study the effect of NGF-β on human ovulation, multiple serial measurements are needed, ideally immediately before and after natural intercourse. Therefore, a patient-friendly and minimally interrupting method is necessary. Serial dried blood spot analysis and saliva sample testing are potential methods, but both are not validated for NGF-β yet. The aim of this study will be to do a method comparison study, to validate the use of both methods compared to venous blood for NGF-β.

Objective: To answer the question if dried blood spot (DBS) analysis and saliva testing are reliable methods to determine the concentration of NGF-▀ in healthy subjects.

Study design: Cross sectional method comparison validation study.

Study population: Healthy human volunteers of reproductive age (18 ľ 43 years).

Main study parameters/endpoints: The main study parameters are the correlation and limits of agreement between dried blood spots/saliva samples compared to venous blood concentration.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The procedure for participants includes one hospital visit or home visit for saliva, dried blood spot and venous blood sampling and a questionnaire has to be completed. There will be no extra risks nor benefits for the participants. The risk analysis for this study concluded the risk for (serious) adverse events is negligible.
- Main changes (audit trail)
- RECORD30-jan-2018 - 8-feb-2018


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl